Taiwan FDA registration 7e2132a8100e9af6850d56d46475bec8

"Bidi" CD4 reagent

TW: “必帝”CD4 試劑

Taiwan·Risk Class 2·BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY·Registered May 07, 2008 – May 07, 2013Cancelled

Registration details

Analysis ID: 7e2132a8100e9af6850d56d46475bec8
Customs Code: DHA00601902402

Company information

Manufacturer: BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY
Manufacturer Country: United States
Authorized Representative: BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)

Product details

Intended Use: CD4試劑用來測量樣本內CD4抗原之存在與否.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.4020 Analysis of specific tests
Import Information: import

Dates and status

Registration Date: May 07, 2008
Expiry Date: May 07, 2013
Cancellation Date: Jun 11, 2015

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期;;許可證已逾有效期

About this record

Access comprehensive regulatory information for "Bidi" CD4 reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7e2132a8100e9af6850d56d46475bec8 and manufactured by BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.